Your browser doesn't support javascript.
loading
Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist.
Nauck, Michael A; Kind, Joachim; Köthe, Lars D; Holst, Jens J; Deacon, Carolyn F; Broschag, Matthias; He, Yan Ling; Kjems, Lise; Foley, James.
Afiliação
  • Nauck MA; Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr University Bochum), Bochum, Germany michael.nauck@rub.de.
  • Kind J; PAREXEL, Berlin, Germany.
  • Köthe LD; Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany.
  • Holst JJ; Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark.
  • Deacon CF; Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark.
  • Broschag M; PAREXEL, Berlin, Germany.
  • He YL; Novartis Institute for BioMedical Research, Cambridge, MA.
  • Kjems L; Novartis Institute for BioMedical Research, Cambridge, MA.
  • Foley J; Novartis Pharmaceuticals, East Hanover, NJ.
Diabetes ; 65(8): 2440-7, 2016 08.
Article em En | MEDLINE | ID: mdl-27207543
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Pirrolidinas / Adamantano / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Nitrilas Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Pirrolidinas / Adamantano / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Nitrilas Idioma: En Ano de publicação: 2016 Tipo de documento: Article